welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
FDA Authorizes First Test to aid in Newborn Screening for Duchenne Muscular Dystrophy
Today, the U.S. Food and Drug Administration authorized marketing of the first test to aid in newborn screening for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.
“Diagnostics that can safely and effectively screen newborns can help health care professionals identify and discuss potential treatment options with parents and caregivers before symptoms or effects on a baby’s health may be noticeable,” said Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health. “This authorization reflects our commitment to fostering innovation in devices to help inform and provide options to patients and their caregivers. Early screening can help identify individuals who need additional follow up or treatment.”

rareRelated
-
Receiver Operating Curve Analyses of Urinary Titin of Healthy 3-y-Old Children May be a Noninvasive Screening Method...Background: Duchenne muscular dystrophy...
-
Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Duri...Duchenne muscular dystrophy (DMD) and Be...
-
CureDuchenne Partners with Baebies to Accelerate Newborn Screening for Duchenne Muscular DystrophyCureDuchenne, the nation’s leading non...
-
Duchenne/Becker Muscular Dystrophy: Advances in reproductive testing optionsDuchenne/Becker Muscular Dystrophy (DMD/...
-
Mosaicism in Carrier of Duchenne Muscular Dystrophy Mutation – Implication for Prenatal DiagnosisObjective: Duchenne muscular dystrophy ...
-
PTC Therapeutics Announces Initial Data from Patient Registry Demonstrating Translarna™ (ataluren) Slows Disease P...PTC Therapeutics, Inc. today announced p...
-
Identification of Duchenne/Becker Muscular Dystrophy Mosaic Carriers Through a Combined DNA/RNA AnalysisObjective The Duchenne/Becker muscular ...